Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

STU:DUL (USA)   Ordinary Shares
€ 137.15 (+1.78%) May 17
At Loss
Market Cap:
€ 17.39B ($ 18.94B)
Enterprise V:
€ 16.40B ($ 17.83B)
Volume:
-
Avg Vol (2M):
44.00
Also Trade In:

Alnylam Pharmaceuticals Inc Valuation Measures